Glasgow University pharma enterprise wins £350,000 grant

Hello and welcome to our daily digest of business, financial and economic news from around Scotland.

1. University of Glasgow spin-out Keltic Pharma Therapeutics has secured a £350,000 grant from Innovate UK to develop treatments for diseases such as asthma.

The funding will support the advancement of Keltic Pharma’s Pepsmol drug-discovery platform, which targets hard-to-treat cell-surface receptors that play a crucial role in many physiological processes. The grant will enable the company to expand its team.

Keltic Pharma, founded by professors Andrew Tobin, Andrew Jameson and Graeme Milligan, aims to develop inhaled synthetic drugs to normalise lung function and reduce inflammation in severe asthma patients.

Innovate UK is part of the UK government and operates under the umbrella of UK Research and Innovation, which is